1.Konstan M.W. Stern R.C. Doershuk C.F. Efficacy of the Flutter VRPI in airway mucus clearance in custic fibrosis. J. of Paediatrics 124 : 689-693 (1994)
2. Casaulta C. Frey U. Schibler A. Kraemer R. Efficacy of chest physiotherapy (CPT) (PEP-mask versus Flutter) in patients with cystic fibrosis (CF), Poster presentation at the 1993 ERS, Florence, Italy (25-29 Sept. 1993). Eur. Resp. J. 6 (Suppl. 17, Sept. 1993 : 220s (abstract P0459)
3. Schibler A. Casaulta C. Kraemer R. Rationale of oscillatory breathing as chest physiotherapy performed by the Flutter in patients with cystic fibrosis (CF). Presentation at the 6th Annual North American Cystic Fibrosis Conference, Washington, U.S.A, 15-18 Oct. 1992. Ped. Pulmonol. Suppl. 2, Sept. 1992 : 301 (Abstract 244)
4. Lindemann H. Evaluation of VRP1 physiotherapy, Pneumologie 46 : 626-630 (1992).
5. Huls G. Lindemann H. Comparison between two physiotherapeutic methods : the Flutter VRP1 and autogenic drainage : Atemw.-und Lungenkrankheiten 17 : 414 (1991).
6. Althaus P. Leuenberger P. Roulet M. Comparison of the PEP-Mask and the Flutter VRP1 in the bronchial hygiene of cystic fibrosis patients. Presentation at the union Annuelle Commune de la Société Suisse de Cardiologie et de la Société Suisse de Pneumologie, Lugano, Switzerland, 27-29 April 1989. Schw. Med/ Wschr. 199, suppl. 27 : 39 (1989)
7. Weiner P. Azgad Y. Weiner M. Oscillatory breathing using the Flutter VRP1 as chest physiotherapy in patients with chronic obstructive pulmonary disease. Am. J. Resp. Crit. Care Med. 149 : A579 (abstract) (1994).
8. Ambrosino N. Oscillating positve expiratory pressure versus postural drainage in patients other then cystic fibrosis. Am. J. Resp. Crit. Care Med. 149 : A579 (abstract) (1994).
9.Celga U. E. Physiotherapy and chronic obstructive bronchitis. Experiments with the VRP1 Destin). Pneumologie 47 : 636-639 (1993).
10. Köhler D. Effects of physiotherapy with VRP1 Destin (Flutter) on lung function, bronchial clearance and lung ventilation. Presentation at the 1992 Congress of the European Respiratory Society (ERS), Vienna, Austria, 29 Aug. -3 Sept. 1992. Eur. Resp. J. 5 (Suppl.15) : 195 s (Abstract PO626).
11. Ambrosino N. Evaluation of a new device for chest physiotherapy. Presentation (poster) at the "30o Congresso Nazionale dell"Associazione Italiana Pneumologi Ospedalieri", Pisa/Italy, 19-22 Sept. 1990. Rassegna di Patologie delApparato Respiratorio 5, suppl. 1:73 (1990).
12.Vergara P. The Flutter VRP1 with ventilatory control in the treatment of bronchial hypersecretion). Conference at the Congreso "Nacional de Fisioterapia ", Tenerife/Spain, Nov. 1989.
13. Beauvois E. Bernu E. Study of the effects of a short session of Flutter VRP1 on the spirography of patients suffering from obstructive ventilatory troubles. Cah. Kinésithér., fasc. 143, no 3 : 51-55 (1990).
14. Girard J-P. Terki N. The Flutter VRP1 : a new personal pocket therapeutic device used as an adjunct to drug therapy in the management of bronchial asthma. J. Invest. Allergol. Clin. Immunol. 4 (No 1) : 23-27 (1994).
15. Campbell I.A. Swift G.L Rainer T. Saran R. Prescott R.J. Use of Flutter VRP1 in the management of patients with steroid-dependant asthma. Respiration 61 : 126-129, 1994.
16. Petro W. Greger G. Use of VRP1 Desitin in the treatment of asthmatic patients. Atemw. -und Lungenkrkh. 1994.
17. Petro W. Greger G. Use of the VRP1 Desitin (Red. : Flutter VRP) by patients with bronchial hyperactivity). Atemw.-und Lungenkrkh. 1994.
